Biotech Innovator Leen Kawas: How Biomarkers Integrate with AI, Machine Learning Healthcare
Dr. Leen Kawas, managing general partner at Propel Bio Partners, illustrates how biomarkers work alongside AI and machine learning to...
top of page
Entrepreneur, Inventor, Innovator & Leader
Managing General Partner, Propel Bio Partners
Press
Dr. Leen Kawas Shares Insights on Her Next-Level Entrepreneurial Journey
Traveling a high-level entrepreneurial path involves numerous challenges and rewards. The entrepreneur’s focus on innovation often...
Dr. Leen Kawas Highlights Alzheimer’s Diagnosis and Treatment Innovations
Dr. Leen Kawas, co-founder and managing general partner at Propel Bio Partners, discusses innovations within the Alzheimer’s care...
Dr. Leen Kawas Describes The Microbiome of Babies and Its Multigenerational Applications
Dr. Leen Kawas delves into the microbiome of babies, and ways in which key discoveries can be implemented across multigenerational ...
Dr. Leen Kawas Discusses How a Hybrid Work Model Can Offer Balance and Enhance Performance
As the biotechnology industry continues its rapid growth, firms must cultivate a highly skilled workforce dedicated to moving each ...
Dr. Leen Kawas details Blockchain technology’s growth: Beyond crypto and into healthcare
Dr. Leen Kawas highlights how Blockchain technology, typically associated with cryptocurrency, is utilized within the healthcare space....
Dr. Leen Kawas Presents Biotech Industry Updates, Discusses Propel Bio Partners’ Investment Criteria
United States biotechnology companies are currently engaged in an industry-wide regeneration. In February 2023, RBC Capital Markets...
Leen Kawas on Actionable Steps for Women in Biotech to Break the Glass Ceiling in Leadership
The glass ceiling has become a notorious metaphor in the press in recent years for the way that upward mobility of women and other...
Three Best Practices When Outsourcing In A Life Science Company
Outsourcing goes beyond initial logistics and financial factors; significant planning needs to be applied before outsourcing can be ...
Former Athira CEO on her controversial exit: 'I was relieved that it came to an end'
Leen Kawas doesn’t worry about what she can’t control. She was a rising star in the biotech scene in 2014 when she became CEO of what was...
How To Break The Leadership Glass Ceiling In The Biotech Industry
Leen Kawas, the co-founder and managing general partner at Propel Bio Partners, said, “if we don’t like the statistics of women-led...
Cues and Views: Propel Bio Partners Managing General Partner Leen Kawas, in brief
Home: Seattle, WA and Los Angeles, CA. Age: 36. Birthplace: Jordan. Profession: Entrepreneur, inventor and investor in the health care...
Dr. Leen Kawas: Investing in a Brighter Future!
Dr. Leen Kawas is best known for co-founding and leading Athira Pharma/M3 Biotechnology corporate and technological development and her ...
Propel Bio Partners Launches With Backing of Richard Kayne
The firm, co-led by the Kayne Anderson co-founder, seeks $150 million for its first fund Kayne Anderson Capital Advisors co-founder...
Former Athira CEO Leen Kawas Reemerges at Startup Propel Bio Partners
Following her ouster as CEO of Athira Pharma, Leen Kawas has found a new home, co-founding Los Angeles-based Propel Bio Partners, an...
Dr. Leen Kawas on How Motherhood Helps Make Women Strong Business Leaders
When you think about it, business, like family, is all about relationships. The very tenets that keep a family functional and ...
Leen Kawas Co-Founds New Investment Firm with the Help of Early Athira Investors
Dr. Leen Kawas was the first woman in Washington state to lead a biotech company to its public debut in 20 years. As the co-founder of...
Leen Kawas Joins Propel Bio Partners
Leen Kawas, the co-founder of Athira Pharma, has launched a new venture based in Los Angeles and Seattle. She is now the co-founder and...
Propel Bio Partners Commences Operations
Co-founded by Richard Kayne of Kayne Anderson and biotech executive, Dr. Leen Kawas, Propel will support entrepreneurs advancing...
Leen Kawas' comeback: a new fund for life sciences start-ups
When I did a column five years ago citing a comment from Melinda Gates to a large audience of women that the technology industry was...
bottom of page